BioSpace News Archive

NeutriSci International Inc. (“NeutriSci” or the “Company”) (TSX-V:NU)(OTCQB:NRXCF)(FRANKFURT:1N9), an innovative technology company developing products for the nutraceutical industry, in conjunction with its manufacturing partner, Cryopharm, is pleased to announce the latest business developments.

Mopec —a leading provider of high-quality pathology, anatomy, mortuary, and necropsy equipment and products—today announced the appointment of Richard Leach as Government Sales and Contracts Manager. Leach

xCures, a clinical study platform provider, announces the US Food and Drug Administration (FDA) granted their IND for an intermediate Expanded Access Program (EAP) for the ERK inhibitor ulixertinib (BVD-523).

Palette Life Sciences, a fully integrated life sciences company, today announced it has partnered with EVERSANA™, a leading provider of commercial services to the life science industry, to enhance market access, commercialization, and distribution activities of Solesta™ in the United States.

The 2020 OPEN MINDS Executive Leadership Retreat will take place virtually October 27 – 29. The Retreat is the only event in the health and human services industry that fully prepares executives to lead their organizations in turbulent times while leveraging ample opportunities for personal development. This unique experi

DTx Pharma, Inc. (DTx), a privately-held biotechnology company creating novel RNA-based therapeutics to treat the genetic drivers of disease, announced today that Arthur T. Suckow , Ph.D., CEO of DTx Pharma, will be presenting a company overview and will participate in 1x1 meetings at the Chardan Virtual 4 th Annual Genetic Medicin

Akero Therapeutics, Inc. (Nasdaq: AKRO), a clinical-stage biotechnology company developing transformational treatments for patients with non-alcoholic steatohepatitis (NASH) and other serious metabolic disorders, today announced that Andrew Cheng , chief executive officer of Akero, will present virtually at the H.C

Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY), the leading RNAi therapeutics company, announced today that management will present a company overview at the Chardan Virtual 4 th Annual Genetic Medicines Conference on Monday, October 5, 2020 at 4:15 pm ET via webcast. A live audio webcast of the presentation will be availa

Molina Healthcare, Inc. (NYSE: MOH) today announced details for the release of its results for the third quarter ended September 30, 2020. Molina Healthcare will issue its earnings release for the third quarter of 2020 after the market closes on Wednesday, October 28, 2020, and will host a conference call and webcast to discuss the earnings release on Thursday, October 29, 2020, at 8:00 a.m. Eastern Time. To access this interactive teleco

Facility Addresses the Shortage of Vaccine Production Capacity in the U.S. When Fully Operational the ADC Is Expected to be Capable of Manufacturing Clinical Trial Quality Vaccines, I ncluding Vaccines Under Development for COVID-19 CHATHAM, N.J., Sept. 28, 2020 (GLOBE NEWSWIRE) -- Tonix Pharmaceuticals Holding Corp. (Nasdaq: TNXP) (Tonix or the Company), a clinical-stage biopharmaceutical company, completed the purchase a 40,000 square foot facility in Massachusetts to house its new